Cargando…

Metabolomics of Esophageal Squamous Cell Carcinoma Tissues: Potential Biomarkers for Diagnosis and Promising Targets for Therapy

BACKGROUND: The incidence of esophageal squamous cell carcinoma in China ranks first in the world. The early diagnosis technology is underdeveloped, and the prognosis is poor, which seriously threatens the quality of life of the Chinese people. Epidemiological findings are related to factors such as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jia, Cao, Weiping, Shao, Aizhong, Yang, Ming, Andoh, Vivian, Ge, Qi, Pan, Hui-wen, Chen, Ke-ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246618/ https://www.ncbi.nlm.nih.gov/pubmed/35782075 http://dx.doi.org/10.1155/2022/7819235

Ejemplares similares

Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging
por: Xu, Jing, et al.
Publicado: (2016)

Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Pan Pan, et al.
Publicado: (2022)

Serum Metabolomics for Biomarker Screening of Esophageal Squamous Cell Carcinoma and Esophageal Squamous Dysplasia Using Gas Chromatography-Mass Spectrometry
por: Zhang, Su, et al.
Publicado: (2020)

Plasma Metabolomics Reveals Diagnostic Biomarkers and Risk Factors for Esophageal Squamous Cell Carcinoma
por: Yu, Mengjie, et al.
Publicado: (2022)

Tissue-derived exosome proteomics identifies promising diagnostic biomarkers for esophageal cancer
por: Rao, Dingyu, et al.
Publicado: (2023)

Identification of Plasma Metabolomic Profiling for Diagnosis of Esophageal Squamous-Cell Carcinoma Using an UPLC/TOF/MS Platform
por: Liu, Ran, et al.
Publicado: (2013)

Untargeted Metabolomics Analysis of Esophageal Squamous Cell Carcinoma Discovers Dysregulated Metabolic Pathways and Potential Diagnostic Biomarkers
por: Zhu, Zi-Jia, et al.
Publicado: (2020)

Beclin-1 is a Promising Prognostic Biomarker in a Specific Esophageal Squamous Cell Carcinoma Population
por: Du, Hailei, et al.
Publicado: (2021)

(1)H-NMR spectroscopy identifies potential biomarkers in serum metabolomic signatures for early stage esophageal squamous cell carcinoma
por: Liu, Yan-Yan, et al.
Publicado: (2019)

Caspase recruitment domain family member 9 expression is a promising biomarker in esophageal squamous cell carcinoma
por: Sekino, Nobufumi, et al.
Publicado: (2019)

Serum metabolomics analysis for the progression of esophageal squamous cell carcinoma
por: Li, Xia, et al.
Publicado: (2021)

Untargeted metabolomics analysis of esophageal squamous cell cancer progression
por: Yang, Tao, et al.
Publicado: (2022)

Biomarkers for the Clinical Diagnosis of Alzheimer’s Disease: Metabolomics Analysis of Brain Tissue and Blood
por: Wang, Yang-Yang, et al.
Publicado: (2021)

A serum metabolomics analysis reveals a panel of screening metabolic biomarkers for esophageal squamous cell carcinoma
por: Lv, Jiali, et al.
Publicado: (2021)

Metabolomics as a promising tool for early osteoarthritis diagnosis
por: de Sousa, E.B., et al.
Publicado: (2017)

Challenges in Metabolomics-Based Tests, Biomarkers Revealed by Metabolomic Analysis, and the Promise of the Application of Metabolomics in Precision Medicine
por: Di Minno, Alessandro, et al.
Publicado: (2022)

Upregulation of Centromere Proteins as Potential Biomarkers for Esophageal Squamous Cell Carcinoma Diagnosis and Prognosis
por: Wang, Xiao, et al.
Publicado: (2022)

Immune Infiltration Represents Potential Diagnostic and Prognostic Biomarkers for Esophageal Squamous Cell Carcinoma
por: Li, Mengxiang, et al.
Publicado: (2022)

A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma
por: Zhou, Xin, et al.
Publicado: (2017)

Salivary MicroRNAs as Promising Biomarkers for Detection of Esophageal Cancer
por: Xie, Zijun, et al.
Publicado: (2013)

Cell-Free DNA Fragmentomics: The Novel Promising Biomarker
por: Qi, Ting, et al.
Publicado: (2023)

The early diagnosis and monitoring of squamous cell carcinoma via saliva metabolomics
por: Wang, Qihui, et al.
Publicado: (2014)

Possible biomarkers for predicting lymph node metastasis of esophageal squamous cell carcinoma: a review
por: Li, Juan, et al.
Publicado: (2019)

ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal Carcinogenesis/Esophageal Squamous Cell Carcinoma
por: Li, Juan, et al.
Publicado: (2022)

Machine Learning and Novel Biomarkers Associated with Immune Infiltration for the Diagnosis of Esophageal Squamous Cell Carcinoma
por: Zhang, Jipeng, et al.
Publicado: (2022)

XRCC3 is a promising target to improve the radiotherapy effect of esophageal squamous cell carcinoma
por: Cheng, Jingjing, et al.
Publicado: (2015)

A review of the most promising biomarkers for early diagnosis and prognosis prediction of tongue squamous cell carcinoma
por: Hussein, Aisha A., et al.
Publicado: (2018)

Tissue metabolomics identified new biomarkers for the diagnosis and prognosis prediction of pancreatic cancer
por: Liu, Chang, et al.
Publicado: (2022)

Autoantibodies as Potential Biomarkers for the Early Detection of Esophageal Squamous Cell Carcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2014)

Identification and Validation of Common Reference Genes for Normalization of Esophageal Squamous Cell Carcinoma Gene Expression Profiles
por: Xu, Jia, et al.
Publicado: (2022)

Biomarkers of apoptosis and survival in esophageal squamous cell carcinoma
por: Takikita, Mikiko, et al.
Publicado: (2009)

Metabolomics based plasma biomarkers for diagnosis of oral squamous cell carcinoma and oral erosive lichen planus
por: Li, Xibo, et al.
Publicado: (2022)

Fucosylated exosomal miRNAs as promising biomarkers for the diagnosis of early lung adenocarcinoma
por: Chen, Xiongfeng, et al.
Publicado: (2022)

Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2017)

Endoscopic diagnosis and treatment of early esophageal squamous neoplasia
por: Shimamura, Yuto, et al.
Publicado: (2017)

Prognostic biomarkers of cervical squamous cell carcinoma identified via plasma metabolomics
por: Zhou, Huihui, et al.
Publicado: (2019)

Apoptosis-associated biomarkers in tuberculosis: promising for diagnosis and prognosis prediction
por: Shu, Chin-Chung, et al.
Publicado: (2013)

Metabolomics as a Promising Resource Identifying Potential Biomarkers for Inflammatory Bowel Disease
por: Bauset, Cristina, et al.
Publicado: (2021)

Combined Metabolomic Analysis of Plasma and Tissue Reveals a Prognostic Risk Score System and Metabolic Dysregulation in Esophageal Squamous Cell Carcinoma
por: Chen, Zhongjian, et al.
Publicado: (2020)

Quantitative immunohistochemistry (IHC) analysis of biomarker combinations for human esophageal squamous cell carcinoma
por: Gao, Jiebing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f6o9kt890b5n7cnujmsv88mps1